Sana Biotechnology, Inc. (SANA): A Bull Case Theory 

We came across a bullish thesis on Sana Biotechnology, Inc. on Stock Invader’s Substack. In this article, we will summarize the bulls’ thesis on SANA. Sana Biotechnology, Inc.'s share was trading at $4.00 as of February 9th.

[caption id="attachment_400243" align="aligncenter" width="750"] Elena Pavlovich/Shutterstock.com[/caption]

Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines in the United States. SANA has emerged as a compelling player in the race to cure type 1 diabetes (T1D) with its gene-edited, hypoimmune cell...